logo-loader
viewFSD Pharma

FSD Pharma explains how its 'doubling down' on biosciences division

FSD Pharma Inc's (CSE:HUGE) (NASDAQ:HUGE) Dr Ed Brennan sat down with Proactive’s Christine Corrado at the Biotech Showcase 2020 in San Francisco. Dr Brennan spoke about the company's recent achievement, and how it plans to double down on its biosciences division.

Quick facts: FSD Pharma

Price: 9.8 CAD

CSE:HUGE
Market: CSE
Market Cap: $76.6 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of FSD Pharma named herein, including the promotion by the Company of FSD Pharma in any Content on the Site, the Company receives from said issuer...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: FSD Pharma takes major step forward listing on Nasdaq under...

FSD Pharma (NASDAQ: HUGE-CSE: HUGE) Executive Co-Chairman and CEO Dr Raza Bokhari, joined Steve Darling from Proactive Vancouver to discuss the company listing on the Nasdaq stock exchange under ticker “HUGE” Dr Bokhari what this step means for the company. Dr Bokhari also told Proactive...

1 week, 6 days ago

2 min read